InsidersTradesSigma
Follow the AstraZeneca PLC share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, AstraZeneca PLC has recorded 1 public disclosures. Market capitalisation: €195.3bn. The latest transaction was filed on 7 August 2026 (Attribution). Among the most active insiders: Sharma Mani. The full history is openly available.
Analysts rate AstraZeneca PLC Buy (bullish), based on 22 analysts. Average price target: £15,772.18.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
AstraZeneca PLC 是一家全球性制药公司，专注于肿瘤、心血管和呼吸系统疾病领域药物的研发和商业化。该公司在斯德哥尔摩证券交易所上市，股票代码为 XSTO。
AstraZeneca trades with healthcare inflows and a fresh trial setback, while the only recent insider move was a small Aug...
AstraZeneca fell on merger reports with Bristol Myers Squibb, after strong first-half results and no fresh insider trade...